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Amiodarone (AMIO), the most frequently antiarrhythmic drug used for the symptomatic treatment of chronic Chagas’ disease
patients with cardiac compromise, has recently been shown to have also speciﬁc activity against fungi, Trypanosoma cruzi and
Leishmania. In this work, we characterized the eﬀects of AMIO on proliferation, mitochondrial physiology, and ultrastructure of
Leishmaniaamazonensis promastigotesandintracellular amastigotes.TheIC50 valueswere 4.21and0.46μM againstpromastigotes
and intracellular amastigotes,respectively, indicating high selectivity for the clinically relevant stage.We also found that treatment
with AMIO leads to a collapse of the mitochondrial membrane potential (ΔΨm) and to an increase in the production of reactive
oxygen species, in a dose-dependent manner. Fluorescence microscopy of cells labeled with JC-1, a marker for mitochondrial
energization,and transmissionelectron microscopy conﬁrmedsevere alterationsof the mitochondrion,including intense swelling
and modiﬁcation of its membranes. Other ultrastructural alterations included (1) presence of numerous lipid-storage bodies,
(2) presence of large autophagosomes containing part of the cytoplasm and membrane proﬁles, sometimes in close association
with the mitochondrion and endoplasmic reticulum, and (3) alterations in the chromatin condensation and plasma membrane
integrity. Taken together, our results indicate thatAMIO is a potent inhibitor ofL. amazonensis growth, acting through irreversible
alterations in the mitochondrial structure and function, which lead to cell death by necrosis, apoptosis and/or autophagy.
1.Introduction
Leishmaniasis is a parasitosis caused by diﬀerent species of
the Leishmania genus that aﬀects about 12 million people
around the world, with 90% of the cases reported in
Afghanistan, Pakistan, Iran, Iraq, Syria, Saudi Arabia, India,
Bangladesh, Nepal, Sudan, Algeria, Ethiopia, Brazil, Bolivia,
Colombia, Ecuador, Peru, and Venezuela [1]. Approximately
21 species have been described to cause three diﬀerent
clinicalmanifestations: (1)cutaneous(CL),wherethelesions
are conﬁned to the site of the inoculation by the sandﬂy; (2)
mucocutaneous (MCL), which aﬀects the mucosal tissues;
(3) visceral (VL), where the parasites have a tropism for
phagocytes mainly localized in the spleen and the liver.
Visceral leishmaniasis is fatal if not treated, while some
forms of cutaneous manifestations can cure spontaneously.
According to WHO, around 70,000 deaths per year occur
throughout the world [1]. In Brazil, Leishmania amazonensis
is one of the species responsible for the cutaneous disease;
however, in some individuals the immune system fails to2 Molecular Biology International
mount an appropriate response against the parasite, leading
to clinical manifestations of diﬀuse cutaneous leishmaniasis
[2].
Pentavalent antimonials such as meglumine antimoniate
(Glucantime) and sodium stibogluconate (Pentostan) have
been employed as ﬁrst-line treatment for many decades [3].
In the case of resistance to pentavalent antimonials, second-
line treatments using amphotericin B or pentamidine have
been successfully used [4]. For visceral leishmaniasis, milte-
fosine (Impavido) has been recently employed by oral route
in India as a ﬁrst-line treatment [5]. However, the drug
is teratogenic and has a narrow chemotherapeutic window
[6]. More recently, combination treatments are emerging as
ﬁrst-line treatments for visceral leishmaniasis [7]. Toxic side
eﬀects and increasing resistance limit most of the current
speciﬁc treatments for leishmaniasis, indicating that there is
anurgentneedtodevelopnewdrugsthatareeﬃcacious,safe,
and more accessible for the patient populations.
Amiodarone (AMIO) is the antiarrhythmic class III drug
most frequently used to treat arrhythmias in general as
well as in patients with chronic Chagas’ disease and cardiac
compromise. The antiarrhythmic action in mammals has
beenwell characterized andresultsfromCa2+ andK+channel
inactivation, but it has recently been shown that the drug
also has selective activity against parasitic protozoa such
as Trypanosoma cruzi and Leishmania mexicana [8–10]a s
well as a broad-spectrum antifungal action [11, 12]. The
mechanisms of action of AMIO reported in these diﬀerent
microorganisms involve the inhibition of sterol biosynthesis,
disruption of mitochondrial membrane potential (ΔΨm),
and Ca2+ homeostasis, as well as production of reactive
oxygen species [8, 9, 11–13]. Apparently, these alterations in
the mitochondrial metabolism trigger a sequence of cellular
events leading to apoptosis-like cell death [13]. However,
the action of AMIO on the mitochondrion of target cells
is controversial, as some groups have implicated inhibition
of mitochondrial respiration, mainly by the direct action
of AMIO against complex I, II, and F0F1-ATP synthase
[13] or by a rapid release of Ca2+ from the mitochondrial
compartment due to a collapse of mitochondrial membrane
potential(ΔΨm)(s ee[8, 9]),while otherssuggest thatAMIO
is able to protect mitochondrial function [14–17].
In this study, we investigated the antiproliferative, ultra-
structural, and physiological eﬀects of amiodarone on pro-
mastigote and intracellular amastigote forms of Leishmania
amazonensis. The results indicated that AMIO acts mainly by
altering the mitochondrial ultrastructure and physiology but
other deleterious eﬀects were also observed, including lipid
accumulation, loss of the plasma membrane integrity, and
presence of autophagic-like structures, suggesting diﬀerent
types of cell death involved in the mechanism of action of
AMIO.
2.MaterialandMethods
2.1. Parasites. MHOM/BR/75/Josefa strain of Leishmania
amazonensis isolated from a patient with diﬀuse cuta-
neous leishmaniasis by C. A. Cuba-Cuba (Universidade
de Brasilia, Brazil) was used in the present study. It has
been maintained by hamster footpad inoculation and, in
the case of promastigotes, axenically cultured in Warren’s
medium (brain heart infusion plus hemin and folic acid)
[18] supplemented with 10% fetal bovine serum at 25◦C.
Infective promastigotes of the Josefa strain were used to
obtain intracellular amastigotes in macrophage cultures.
2.2. Drug. Amiodarone (AMIO), {(2-butyl-3-benzofuranyl)
-[4-[2-(diethylamino)ethoxi]-3,5-diiodophenyl]methanone
hydrochloride}, was purchased from Sigma, dissolved in
dimethyl sulfoxide as a 100mM stock, and stored at −20◦C.
2.3. In Vitro Antiproliferative Activities of Amiodarone.
Growth experiments with promastigotes were initiated with
2.0 × 106 parasites/mL, and AMIO was added at diﬀerent
concentrations from concentrated stock solutions in DMSO
after 24h of growth. Cell densities were evaluated daily in
a Neubauer chamber during 72h of growth. To evaluate
the eﬀects of the AMIO on the L. amazonensis intracellular
amastigotes, peritoneal macrophages from CF1 mice were
harvested by washing them with RPMI medium (Gibco) and
platedin24-welltissueculturechamberslides,allowingthem
to adhere to the slides for 24 h at 37◦Ci n5 %C O 2. Adherent
macrophages were infected with metacyclic promastigotes
at a macrophage-to-parasite ratio of 1:10 at 35◦Cf o r
2h. After this time, noningested parasites were removed
by washing and infected cultures were incubated for 24h
in RPMI (containing 10% of fetal bovine serum) without
AMIO. Diﬀerent concentrations of AMIO were added after
24h of interaction, when the number of amastigotes per
macrophage was in the range of two to four, and fresh
medium with AMIO was added daily for 2 days. The
cultures were ﬁxed with 4% freshly prepared formaldehyde
in phosphate buﬀer saline (PBS, pH 7.2) and stained with
Giemsa for 15min. The percentage of infected cells was
determined by light microscopy. Association indexes (mean
number of parasites internalized per cell, multiplied by
the percentage of infected macrophages, and divided by
the total number of macrophages) were determined and
used as a parameter to calculate the intensity of infection
in each condition used in this study. The 50% inhibitory
concentrations (IC50s) were calculated with the SigmaPlot
(version 10) program. The results are expressed as the means
of three independent experiments.
2.4. Tests of Viability in Macrophages. To evaluate the
cytotoxicity eﬀects of AMIO against the host cell cultures,
macrophages were incubated with diﬀerent concentrations
of AMIO for 48h, and exclusion tests with 0.1% trypan blue
were carried outfor 5min. The percentagesof dead and alive
cells were determined after counting of 400 macrophages in
randomly selected ﬁelds by light microscopy.
2.5. Estimation of Mitochondrial Transmembrane Electric
Potential (ΔΨm). ΔΨm of the control and AMIO-treated
(6,10, and 15μM) promastigotes was investigated usingMolecular Biology International 3
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Figure 1: Antiproliferative and cytotoxic eﬀects of amiodarone (AMIO) on Leishmania amazonensis promastigotes and intracellular
amastigotes. (a) Treatment of promastigotes with diﬀerent concentrations of AMIO for 48h. (b) Eﬀects of amiodarone on intracellular
amastigote forms cultivated in macrophages. Murine host cells were cultivated for 24h and infected with metacyclic promastigotes for
2h. After 24h of infection, AMIO at diﬀerent concentrations was added to the cultures and treatment maintained for 48h, with fresh
medium with drug added every 24h. (c) The cytotoxicity of AMIO was also evaluated in noninfected murine macrophages. After treatment
with AMIO for 48h, the macrophages were incubated with Trypan Blue and 400 cells were counted in randomly chosen ﬁelds under light
microscopy. The experiments were carried out in triplicate, and the bars represent the standard deviation. Statistical analyses were obtained
in Prism Software using 2-way ANOVA. The values of p were obtained comparing the control group with the treated groups: ∗∗∗P<. 001.
the JC-1 ﬂuorochrome, which is a lipophilic cationic mi-
to-chon-dri-al vital dye that becomes concentrated in the
mitochondria in response to ΔΨm.T h ed y ee x i s t sa sa
monomer at low concentrations, where the emission is
530nm (green ﬂuorescence), but at higher concentrations it
formsJ-aggregates afteraccumulationin themitochondrion,
where the emission is 590nm (red ﬂuorescence). Thus, the
ﬂuorescence of JC-1 is considered an indicator of an ener-
gized mitochondrial state, and it has been used to measure
the ΔΨm in Leishmania [19–21]. Control and AMIO-treated
promastigotesafter 48h oftreatment were harvested,washed
in PBS, pH 7.2, added to a reaction medium containing
125mM sucrose, 65mM KCl, 10mM HEPES/K+ pH 7.2,
2mM Pi, 1mM MgCl 2, and 500μME G T A ,a n dc o u n t e d
in a Neubauer chamber. To evaluate the ΔΨm for each
experimental condition, 2.0 × 107 parasites were incubated
in 10μg/mL JC-1 during 30min, with readings made every
1min using a Molecular Devices Microplate Reader (a spec-
troﬂuorometer SpectraMax M2/M2e). Cells were incubated
in the presence of oligomycin (10μM), a F0F1-ATP synthase
inhibitor, or FCCP (1μM), a mitochondrial protonophore,
during the 30min of experiment as positive controls of
the depolarization of the mitochondrial membrane. FCCP
at the concentration of 2μMw a sa d d e da tt h ee n do fa l l4 Molecular Biology International
experiments to abolish ΔΨm. This allowed comparison of
the magnitude of ΔΨm under the diﬀerent experimental
conditions. The relative ΔΨm value was obtained calculating
the ratio between the reading at 590nm and the reading
at 530nm (590:530 ratio). Control and AMIO-treated
promastigotes were also observed under a Zeiss Axioplan
epiﬂuorescence microscope using diﬀerent optical ﬁlter sets:
(1) for J-aggregate alone, we used 546nm band-pass ﬁlter
for excitation, with a 580nm beam splitter, and a 590nm
long-pass for emission; (2) for monomer and J-aggregate,
together,we useda 450–490nmforexcitation,with a510nm
beam splitter, and a 520nm long pass for emission. Each
experiment wasrepeated atleast three timesintriplicate,and
the ﬁgures shown are representative of these experiments.
2.6. Measurements of ROS Levels. Intracellular ROS levelwas
measured in intact control and AMIO-treated promastigotes
as described previously [19]. Brieﬂy, cells (3.0 × 107)w e r e
washed, resuspended in 500μL of PBS pH 7.2, and then
incubated with the cell-permeable probe green H2DCFDAat
aconcentrationof10μg/mLfor1hat25◦C.Afterincubation,
cells were analyzed at a Molecular Devices Microplate
Reader (a spectroﬂuorometer SpectraMax M2/M2e, Molec-
ular Devices) using a pair of 507nm and 530nm as emission
and excitation wavelengths, respectively.
2.7. Evaluation of Membrane Integrity and Nile Red Accu-
mulation. Control and AMIO-treated (6,10, and 15μM)
promastigotes were harvested, washed in PBS, pH 7.2, and
counted in a Neubauer chamber. After that, cells (5.0 ×
106) were incubated with 1μMS Y T O XB l u ea n d1 0μg/mL
Nile Red for 20 minutes. The experiments were made in
triplicate, using a black 96-well plate. The ﬁnal volume
in each well was 200μL of cell suspension in PBS. The
reading was done in a Molecular Devices Microplate Reader
(a spectroﬂuorometer SpectraMax M2/M2e) according to
the following wavelengths for excitation and emission,
respectively: 444 and 560nm for SYTOX Blue, and 485 and
538nm for the Nile Red. After the readings, control and
AMIO-treated cells were observed under a Zeiss Axioplan
epiﬂuorescence microscope equipped with optical ﬁlters to
SYTOX Blue (the same of DAPI) and Nile Red (450–490nm
for excitation, and 528nm for emission). Each experiment
was repeated at least three times in triplicate, and the ﬁgures
shown are representative of these experiments.
2.8. Electron Microscopy. Control and AMIO-treated pro-
mastigotes were ﬁxed for 3 h at 4◦C in 2.5% glutaraldehyde
(Sigma Chemical Co.) in 0.1M cacodylate buﬀer (pH 7.2).
After ﬁxation, cells were postﬁxed for 30 min in a solution
containing 1% OsO4 and 1.25% potassium ferrocyanide
in 0.1 M cacodylate buﬀer, washed in the same buﬀer,
dehydrated in acetone, and embedded in EPON. Ultrathin
s e c t i o n sw e r es t a i n e dw i t hu r a n y la c e t a t ea n dl e a dc i t r a t ea n d
observed in a Zeiss 900 electron microscope.
3.Resultsand Discussion
3.1. Antiproliferative Eﬀects. L. amazonensis promastigotes
were exposed to diﬀerent concentrations of AMIO, and
their proliferation was followed during 4 days. Figure 1(a)
shows a concentration-dependent inhibition of the growth
induced by the treatment. The 50% inhibitory concentration
(IC50) was 4.21μM after 48h of treatment. Inhibition of
around 100% was obtained with a concentration of 15μM
AMIO, which also induced a delayed lytic eﬀect. We also
investigated theeﬀectsofAMIOonintracellularamastigotes,
the clinically relevant form of the parasite. Macrophages
were infectedwithmetacyclicpromastigotesandtreatedwith
diﬀerent concentrations of the drug. The IC50 obtained was
0.46μMa f t e r4 8ho ft r e a t m e n t ,w i t hat o t a le l i m i n a t i o n
of amastigotes when macrophages were treated with 6μM
for 48h (Figure 1(b)). Detailed inspection of treated cultures
using light microscopy conﬁrmed the potent antiprolifer-
ative eﬀect against intracellular amastigotes, as no intact
parasites were seen after treatment with concentrations
≥6μMo fA M I Of o r4 8h( Figure 2).
Comparing our results with those published for L.
mexicana [9], another species of the same Leishmania
subgenus but that is not relevant for the epidemiology of
leishmaniasis in Brazil, the IC50 values found in this study
were higher for both stages (4.21μM for promastigotes and
0.46μM for intracellular amastigotes compared with 900nM
and 8nM, respectively, for L. mexicana), indicating a lower
susceptibility of our L. amazonensis strain to the drug. These
results are consistent with the known fact that patients
infected with L. amazonensis are less responsive to the
available anti-Leishmania treatments [2]. It is interesting to
point out that the clinically relevant intracellular amastigote
form of the parasite had a ten-fold higher susceptibility to
amiodarone than the extracellular promastigotes, a result
similar tothoseobtainedforT. cruzi [8]an dL.mexicana [9].
Using the cytotoxicity trypan blue test, viable cells
were evaluated in macrophage cultures exposed to AMIO
at concentrations varying between 2 and 50μMf o r4 8 h
(Figure 1(c)). The cytotoxicity concentration to reduce 50%
(CC50) of viable macrophages was 12.9μM( Figure 1), giving
a mean selectivity index of 28. Light microscopy showed that
macrophages treated with 6 and 8μM AMIO did not present
any signiﬁcant alteration (Figure 2). In several mammalian
cell lines, AMIO has been described to be very toxic [17, 22,
23]. However, the selectivity of AMIO for trypanosomatid
parasites over mammalian cells and organisms has been
conﬁrmed in experimental models of Chagas’ disease and
leishmaniasis [8–10] and more recently in clinical studies
[24, 25].
3.2.EﬀectsofAMIOontheNeutralLipidAccumulationandon
t h eF i n eS t r u c t u r eo fL .a m a z o n e n s i sP r o m a s t i g o t e s .In order
to evaluate the eﬀect of AMIO on the plasma membrane
integrity and the presence of lipid-storage bodies in L.
amazonensis promastigotes, we performed a quantitative
analysis after simultaneous incubation of the cells with
SYTOX Blue and Nile Red. The results indicated that at
the higher concentration used (15μMA M I O ) ,t h ep l a s m aMolecular Biology International 5
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Figure2:LightmicroscopyofintracellularamastigoteformsofLeishmaniaamazonensistreated withdiﬀerentconcentrationsofamiodarone
(AMIO).(a–d) After 24h of treatment, it is possible to observe a signiﬁcantreduction in the parasite number with 6 and 8μMA M I O( c ,d ) .
(e–h) After 48h of treatment, a signiﬁcant reduction was observed in the cultures treated with 3μM AMIO (f). Infection of macrophages
was carried out as described in Materials and Methods and Figure 1. For all the images, the scale bars are similar to those observed in the
panels (a) and (e). (a) Control parasites/24h of treatment, which means 48h of infection; (e) Control parasites/48h of treatment, which
means 72h of infection.6 Molecular Biology International
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Figure 3: Diﬀerential interference contrast microscopy (DIC) and ﬂuorescence microscopy with Nile Red of Leishmania amazonensis
promastigotes untreated (a-b) and treated with diﬀerent concentrations of AMIO (6, 10 and 15μM) for 48h (c–h, resp.). In the treated
promastigotes,images suggest an accumulation of lipid-storage bodies in the cytoplasm, which is concentration dependent. In (g), parasites
treated with 15μM AMIO are completely modiﬁed. The conditions used to harvest the parasites, to incubate with Nile Red and to observe
under the microscopy using the correct ﬁlters sets are described in Materials and Methods.Molecular Biology International 7
N
k
f
m
2μm
(a)
0.5μm
(b)
m
k
N
A
1μm
(c)
m
f
1μm
(d)
E
A
f
m
k
0.5μm
(e)
N
m
2μm
(f)
Figure 4: Diﬀerent ultrastructural alterations on Leishmania amazonensis promastigotes induced by the treatment with amiodarone
(AMIO). (a) Ultrathin section of L. amazonensis promastigotes without treatment, which presents a normal ultrastructure of organelles
such as (mitochondrion) m , (kinetoplast) k , (nucleus) N and (ﬂagellum) f . (b) Electron micrograph of L. amazonensis treated with 5 μM
AMIO for 48 h presenting many vacuoles similarto autophagosomes(stars).(c–e) After treatment with 15 μM AMIO for 24 h, it is possible
to observe the presence of large autophagosomes a associated with endoplasmic reticulum proﬁles (big arrow), lipid bodies (arrowheads),
and alterations in the mitochondrion–kinetoplast complex and chromatin condensation. (f) Promastigotes treated with 20μMA M I Of o r
24h presented drastic alterations and destruction of the cytoplasm, where it is possible to observe the presence of autophagosomes(arrows)
sometimes associatedwith endoplasmicreticulum proﬁle (big arrow).A: autophagosome;f: ﬂagellum;k: kinetoplast;m:mitochondrion; N:
nucleus.
membrane permeability was signiﬁcantly altered (data not
shown). This eﬀectwas not observedat lowerconcentrations
(6 and 10μMA M I O ) .
On the other hand, incubation with Nile Red revealed
a concentration-dependent eﬀect on neutral lipids’ accu-
mulation, which was quantiﬁed by ﬂuorimeter (data not
shown). The visualization of AMIO-treated promastigotes
under ﬂuorescence microscopy revealed the presence of
many lipid bodies positive to Nile Red and randomly
distributed throughout the cytoplasm (Figures 3(a)–3(h)).
The ﬂuorescence images indicate a concentration-dependent
increase in the number of lipid bodies (Figures 3(d), 3(f),
and3(h)),whilediﬀerentialinterferencecontrastmicroscopy
(DIC) revealed an important alteration in the shape of8 Molecular Biology International
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Figure 5: Eﬀects of the AMIO on the mitochondrial function of Leishmania amazonensis promastigotes. (a) Values of ΔΨm were evaluated
during 30min, after which the uncoupler FCCP was added to collapse mitochondrial potential. Cells grown in the presence of two
concentrations of amiodarone, 6 and 15μM, for 48h (curves b and c, resp.) were observed. (b) Eﬀect of oligomycin (10μM) and FCCP
(1μM) in the ΔΨm was alsoevaluated. (c) Production of ROS was measured in the samecells. Control and treated cells were incubated with
H2DCFDA, andthe ﬂuorescence intensity wasmeasured in a Microplate Reader. Fluorescence intensity isexpressed as arbitrary units(A.U.).
The experiments were performed three times, each time in triplicate, and the ﬁgures shown are representative of these experiments.
promastigotes treated with 15μM AMIO, which appeared
roundedandswollen with aclearevidenceoflossofthecyto-
plasmaticcontent(Figure 3(g)),conﬁrming thealterationon
the plasma membrane integrity indicated by SYTOX Blue
staining. These results are consistent with the reported eﬀect
of AMIO on the de novo sterol biosynthesis in T. cruzi [8]
and L. mexicana [9]. Similar results were obtained with L.
amazonensis treated with squalene synthase inhibitors [26].
We also evaluated the eﬀect of AMIO on the ﬁne struc-
tureofL.amazonensis promastigote.Figure 4(a)showsalon-
gitudinal section of a control promastigote presenting diﬀer-
ent organelles such as mitochondrion, nucleus, kinetoplast,
and ﬂagellum with normal ultrastructure. Parasites incu-
bated in the presence of AMIO displayed signiﬁcant mor-
phological changes, which varied from discrete alterations
to a total destruction of the parasite, depending on the drug
concentration and length of incubation. The changes began
to appear with 5μM AMIO after 48h of incubation, when it
was possibletoobservethepresence ofsome vacuolessimilar
to autophagosomes (Figure 4(b), stars). With just 24h of
treatment, but using higher concentrations (15 and 20μM),
several alterations could be observed such as presence of
lipid-storage bodies (arrowheads), large myelin-like ﬁgures
(arrow) with presence ofendoplasmicreticulumproﬁles(big
arrow), and autophagic structures containing cellular debris
(Figures 4(c)–4(f)). These structures could be related to
a degradation of damaged organelle induced by the drug
treatment. In addition, alterations in the mitochondrion,
in the kinetoplast, and in the chromatin condensation
can be observed in Figures 4(c)–4(d).W ea l s oo b s e r v e d
t h ep r e s e n c eo fs e v e r a ls m a l lv e s i c l e si n s i d et h eﬂ a g e l l a r
pocket (Figure 4(e)) and many cells swollen and completely
destroyed after treatment with 15 and 20μMA M I Of o r2 4h
(Figure 4(f)). All these alterations are characteristic of theMolecular Biology International 9
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Figure 6: Diﬀerential interference contrast (DIC) microscopy and ﬂuorescence microscopy with JC-1 of Leishmania amazonensis
promastigotes untreated (a–c) and treated with 15μM AMIO for 48h (d–f). In panels (b) and (c), the accumulation of aggregated-JC1
is observed in the whole extension of the control mitochondrion. In cells treated with 15μM AMIO (e-f), the accumulation of J-aggregates
occurs in some portions of the mitochondrion, indicating a partial dissipation of the ΔΨm. Panels (b) and (e) show an image of the
monomers and J-aggregates together , while panels (c) and (f) show the image of only J-aggregates.
three main types of cell death: apoptosis, necrosis, and
autophagy (reviewed in [27]).
Some of the lipid bodies appeared near the plasma
membrane and the autophagic-like structures, which could
be related, respectively, to alterations of the biophysical
properties of the plasma membrane and degradation of
abnormal lipids that accumulated as a consequence of the
treatment. Thus, alterations of lipid composition resulting
from treatment with AMIO could interfere with plasma
membrane integrity, leading to cell death by necrosis.
3.3. Eﬀects of AMIO on the Mitochondrial Physiology and
Ultrastructure of L. amazonensis Promastigotes. We investi-
gated the eﬀect of AMIO on the mitochondrial function and
ultrastructure using three criteria: mitochondrial transmem-
brane electric potential (ΔΨm) using JC-1 ﬂuorochrome,
production of reactive oxygen species (ROS) using a green
H2DCFDAprobe,andtransmission electronmicroscopy.JC-
1 is a cell-permeant cationic lipophilic ﬂuorochrome that
accumulates in the functional mitochondrion forming red-
ﬂuorescent J-aggregates. On the other hand, mitochondrial
de-energization leads to an accumulation of green ﬂuores-
cencemonomers.Thus,thedecreaseinthered/greenﬂuores-
cenceintensityratio indicatesa collapsein themitochondrial
transmembrane potential. There are some advantages of
using the JC-1: (1) it is not necessary to permeabilize the
cells; (2) it is easy to quantify in a ﬂuorimeter as well as
to observe the process under a ﬂuorescence microscopy.
Promastigotes were treated with 0, 6, 10, and 15μMA M I O
for 48h prior to the analysis of the mitochondrial features.
Incubation with JC-1 for 30min indicated that cells treated
with 6 and 15μM AMIO had a very signiﬁcant reduction
of ΔΨm (Figure 5(a),t r a c e sba n dc )w h e nc o m p a r e dw i t h
the control (untreated) parasites (Figure 5(a),t r a c ea ) .T h e
results indicated a marked reduction in the mitochondrial10 Molecular Biology International
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Figure 7: Ultrathin sections of L. amazonensis promastigotes treated with diﬀerent concentrations of AMIO showing several alterations in
the mitochondrial ultrastructure such as marked swelling (a, c, d, and e) with loss of the matrix content (a), alterationsin the mitochondrial
membrane (arrowheads), and presence of autophagic structures near a modiﬁed mitochondrion (b). A: autophagic structure; F: ﬂagellum;
k: kinetoplast; M: mitochondrion, N: nucleus.
polarization with 6μMA M I O( Figure 5(a),t r a c eb ) ,a n da n
almost total depolarization of the mitochondrial membrane
potential with 15 μMA M I O( Figure 5(a),t r a c ec ) .A f t e r3 0
min of JC-1 uptake, 2μM FCCP was added to fully collapse
theΔΨm:itcanbeseen thatin controlparasitestherelease of
JC-1 was more prominent than in treated promastigotes. To
compare these ﬁndings with other situations that can induce
depolarization of the mitochondrion, control and treated
parasites were incubated with two classical inhibitors of the
mitochondrial function: olygomicin, which is an inhibitor of
the F0F1-ATP synthase, and FCCP, a classical protonophore
uncoupler that dissipates the mitochondrial electrochemical
H+ gradient (Figure 5(b)). It can be seen that the reduction
of ΔΨm f o u n di nc e l l sg r o w ni nt h ep r e s e n c eo f6a n d1 5μM
AMIO (Figure 5(a)) is similar to those obtained in control
cells incubated with olygomicin or FCCP (Figure 5(b)). In
addition, when these inhibitors were added in AMIO-treated
promastigotes, the decrease of the ΔΨm was more evident.
We also investigated the eﬀect of AMIO on the produc-
tion of reactive oxygen species (ROS), as it is known that
inhibition of oxidative phosphorylation induces an increase
in the production of ROS. The results shown in Figure 5(c)
indicate that cells grown in the presence of AMIO at the
same concentrations used to evaluate the ΔΨm,s h o w e d
very signiﬁcant and concentration-dependent increase in the
production of ROS. The eﬀect was most evident with 10 and
15μMA M I O .
Alterations of the mitochondrion were also investigated
using ﬂuorescence and transmission electron microscopy,
conﬁrming the results obtained at the ﬂuorimeter. Visual-
ization of control and AMIO-treated promastigotes incu-
bated with JC-1 under ﬂuorescence microscopy revealedMolecular Biology International 11
that cells grown with 15μMA M I Of o r4 8 hs h o w e d
reduced accumulation of the ﬂuorochrome, restricted to
the kinetoplast region of the single giant mitochondrion
(Figures 6(e) and 6(f)), indicating a loss of only ΔΨm in
most parts of the organelle. In contrast, in control pro-
mastigotes, JC-1 accumulated in the whole extension of the
ramiﬁed mitochondrion (Figures 6(b) and 6(c)). Images
(b) and (e) show the ﬂuorescence for monomers and J-
aggregates, together, while the images (c) and (f) show the
ﬂuorescence for J-aggregates alone.
Finally, ultrastructural alterations on the mitochondrion
were also investigated: in Figure 7 t h eo c c u r r e n c eo fd r a -
matic modiﬁcations in diﬀerent aspects of the organelle
can be seen. It is evident that long-term incubation with
AMIO induced mitochondrial swelling at all the concen-
trations tested (Figures 7(a), 7(c), 7(d) and 7(e)), which
is followed by alterations in the mitochondrial membranes
(Figures 7(d) and 7(e), arrowheads), appearance of circular
cristae (Figure 7(a) and 7(c)), and loss of the mitochondrial
matrix content (Figures 7(a) and 7(d)). In addition, we
also observed an important interaction between the mito-
chondrion and structures similar to autophagic vacuoles
(Figure 7(c)). In this same ﬁgure, alterations in the kineto-
plast structure are also evident. Ultrastructural alterations
on the mitochondrion also predominate in T. cruzi and
Leishmania cells treated with sterol biosynthesis inhibitors,
including quinuclidine derivatives, azoles and azasterols,
indicating that this organelle is an important target for
compounds that interfere with sterol and lipid composition
[27–35].
The dose-dependent reduction of ΔΨm induced by
amiodarone was correlated with the increase in the pro-
duction of reactive oxygen species and mitochondrial ultra-
structural alterations detected with transmission electron
microscopy. Two possible explanations for these combined
alterations are: (1) Calcium release from the mitochondrion,
which would result from a direct action of AMIO on the
organelle and lead to apoptotic cell death [36]; and, (2)
Sterol biosynthesis inhibition, as observed in fungi [37]a n d
trypanosomatids [8, 9], leading to an important alteration in
the lipid composition of the mitochondrial membranes that
should modify their biophysical properties [28, 38, 39], and
loss of mitochondrial function.
4.Conclusion
In conclusion, the results of this work support the potential
usefulness of AMIO as a chemotherapeutic agent against
Leishmania amazonensis.S u c ha c t i v i t yi sm a i n l ym e d i a t e d
by profound and selective eﬀects on the ultrastructure and
physiology of the parasite mitochondrion, which culminate
in cell death by necrosis, apoptosis, or autophagy. More
studiesare necessary to bettercharacterize thediﬀerenttypes
of cell death associated with the mechanisms of action of
AMIO and the activity of the drug in murine models of
cutaneous leishmaniasis by L. amazonensis.
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